ClinicalTrials.Veeva

Menu

Improvement of Sarcopenia in Patients Following Two Different Diets

C

CHU Brugmann University Hospital

Status

Withdrawn

Conditions

Sarcopenia

Treatments

Dietary Supplement: Oral dietary supplements

Study type

Interventional

Funder types

Other

Identifiers

NCT03405727
CHUB-diet

Details and patient eligibility

About

Sarcopenia is defined as a decrease in muscular strength and muscle mass, accompanied by a decrease in physical performance. Seniors might develop sarcopenia because of a decreased physical activity and a decreased protein intake. Many patients also develop sarcopenia after a long stay in an intensive care unit.

Protein intake is very important when treating sarcopenia. However, meeting the protein requirements at home proves difficult. Oral dietary supplements, given in addition to the other known recommendations, might provide a solution.

This study will assess the efficacy of the oral dietary supplements for the treatment of sarcopenia.

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients hospitalized within the CHU Brugmann, Brussels
  • Patients diagnosed with sarcopenia (by means of a dynamometer)
  • Patients having stayed in an intensive care unit for longer than 5 weeks

Exclusion criteria

  • Oncology patients
  • Anorexic patients
  • Patients having a life expectancy of less than 6 months
  • Demented patients
  • BPCO patients
  • Patients with neuropathies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Standard treatment
No Intervention group
Oral dietary supplements
Experimental group
Treatment:
Dietary Supplement: Oral dietary supplements

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems